-transparent.png){kind=logo}
A number of normal and neoplastic human cell lines in culture were studied by cell count and 3H thymidine incorporation for growth inhibitory effect by the pyrimido-pyrimidine derivative RA-233 (mopidamole). There was more inhibition when the drug was added to the culture in the lag phase than in the logarithmic growth phase. There was more inhibition (particularly at low doses) of the neoplastic cell lines than of the non-neoplastic cell lines.
Related Publications
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
February 1990,
Gynecologic oncology,
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
May 1986,
Methods and findings in experimental and clinical pharmacology,
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
April 1987,
Cancer research,
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
January 1976,
Naunyn-Schmiedeberg's archives of pharmacology,
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
September 1987,
European journal of cancer & clinical oncology,
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
August 1991,
Thrombosis research,
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
January 1976,
Naunyn-Schmiedeberg's archives of pharmacology,
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
June 1960,
Giornale di clinica medica,
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
January 1987,
Journal of medicine,
W Biddle, and
R A Montagna, and
S S Leong, and
J Horoszewicz, and
H Gastpar, and
J L Ambrus
January 1991,
Methods and findings in experimental and clinical pharmacology,
